| Product Code: ETC9267408 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Artificial Intelligence (AI) in Drug Discovery Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Singapore Artificial Intelligence (AI) in Drug Discovery Market - Industry Life Cycle |
3.4 Singapore Artificial Intelligence (AI) in Drug Discovery Market - Porter's Five Forces |
3.5 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Offering, 2021 & 2031F |
3.9 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.10 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Singapore Artificial Intelligence (AI) in Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing RD investments in pharmaceuticals and biotechnology industries in Singapore |
4.2.2 Growing demand for innovative and efficient drug discovery solutions |
4.2.3 Government initiatives and support for AI technology adoption in healthcare sector |
4.3 Market Restraints |
4.3.1 High initial investment required for implementing AI solutions in drug discovery |
4.3.2 Data privacy and security concerns related to AI applications in healthcare |
4.3.3 Lack of skilled professionals in AI and data science in the pharmaceutical industry |
5 Singapore Artificial Intelligence (AI) in Drug Discovery Market Trends |
6 Singapore Artificial Intelligence (AI) in Drug Discovery Market, By Types |
6.1 Singapore Artificial Intelligence (AI) in Drug Discovery Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Novel Drug Candidates, 2021- 2031F |
6.1.4 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Drug Optimization and Repurposing Preclinical Testing and Approval, 2021- 2031F |
6.1.5 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Drug Monitoring, 2021- 2031F |
6.1.6 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Aggregating and Synthesizing Information, 2021- 2031F |
6.1.7 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Formation and Qualification of Hypotheses, 2021- 2031F |
6.1.8 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By De Novo Drug Design, 2021- 2031F |
6.1.9 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Singapore Artificial Intelligence (AI) in Drug Discovery Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Machine Learning, 2021- 2031F |
6.2.3 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Deep Learning, 2021- 2031F |
6.2.4 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Natural Language Processing, 2021- 2031F |
6.2.5 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Singapore Artificial Intelligence (AI) in Drug Discovery Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Small Molecule, 2021- 2031F |
6.3.3 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Large Molecule, 2021- 2031F |
6.4 Singapore Artificial Intelligence (AI) in Drug Discovery Market, By Offering |
6.4.1 Overview and Analysis |
6.4.2 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Software, 2021- 2031F |
6.4.3 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Services, 2021- 2031F |
6.5 Singapore Artificial Intelligence (AI) in Drug Discovery Market, By Indication |
6.5.1 Overview and Analysis |
6.5.2 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Immuno-Oncology, 2021- 2031F |
6.5.3 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.5.4 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.5.5 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Metabolic Diseases, 2021- 2031F |
6.5.6 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Singapore Artificial Intelligence (AI) in Drug Discovery Market, By End Use |
6.6.1 Overview and Analysis |
6.6.2 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Contract Research Organizations (CROs), 2021- 2031F |
6.6.3 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.6.4 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Research Centers and Academic Institutes, 2021- 2031F |
6.6.5 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
7 Singapore Artificial Intelligence (AI) in Drug Discovery Market Import-Export Trade Statistics |
7.1 Singapore Artificial Intelligence (AI) in Drug Discovery Market Export to Major Countries |
7.2 Singapore Artificial Intelligence (AI) in Drug Discovery Market Imports from Major Countries |
8 Singapore Artificial Intelligence (AI) in Drug Discovery Market Key Performance Indicators |
8.1 Number of partnerships between AI technology providers and pharmaceutical companies in Singapore |
8.2 Increase in research publications related to AI in drug discovery in Singapore |
8.3 Growth in the number of AI startups focused on healthcare and pharmaceuticals in Singapore |
9 Singapore Artificial Intelligence (AI) in Drug Discovery Market - Opportunity Assessment |
9.1 Singapore Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Singapore Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Singapore Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Singapore Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Offering, 2021 & 2031F |
9.5 Singapore Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.6 Singapore Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Singapore Artificial Intelligence (AI) in Drug Discovery Market - Competitive Landscape |
10.1 Singapore Artificial Intelligence (AI) in Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Singapore Artificial Intelligence (AI) in Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here